{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:34:58Z","timestamp":1780504498065,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.humimm.2022.12.003","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T21:00:18Z","timestamp":1672779618000},"page":"224-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Unbalanced T-cell subsets in pediatric patients with beta-thalassemia"],"prefix":"10.1016","volume":"84","author":[{"given":"Shideh","family":"Namazi Bayegi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Ali Hamidieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Behfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amene","family":"Saghazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Bozorgmehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Tajik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali-Akbar","family":"Delbandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Delavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Shekarabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2022.12.003_b0005","unstructured":"D.J. Weatherall, The Thalassemias: Disorders of Globin Synthesis, in: K. Edmonson, H. Lebowitz (Eds.), Williams Hematology, James F. Shanahan, United States, 2016, pp. 725-754."},{"issue":"6","key":"10.1016\/j.humimm.2022.12.003_b0010","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/gim.2016.173","article-title":"\u03b2-Thalassemia","volume":"19","author":"Origa","year":"2016","journal-title":"Genet. Med."},{"key":"10.1016\/j.humimm.2022.12.003_b0015","unstructured":"S.B. McKenzie, Clinical laboratory hematology, Lynne Williams, Boston, 2015."},{"issue":"07","key":"10.1016\/j.humimm.2022.12.003_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2155-9864.1000224","article-title":"Immunologic abnormalities in \u03b2-thalassemia","volume":"05","author":"Asadov Ch","year":"2014","journal-title":"J. Blood Disord. Transf."},{"issue":"1","key":"10.1016\/j.humimm.2022.12.003_b0025","first-page":"19","article-title":"Pathogenetic aspects of immune deficiency associated with beta-thalassemia","volume":"9","author":"Farmakis","year":"2003","journal-title":"Med. Sci. Monitor: Int. Med. J. Exp. Clin. Res."},{"issue":"2","key":"10.1016\/j.humimm.2022.12.003_b0030","first-page":"1","article-title":"Natural killer NK cells in \u03b2 thalassemia major patients","volume":"2","author":"Bekaro\u011fl","year":"2014","journal-title":"JSM Biotechnol. Bioeng."},{"issue":"1","key":"10.1016\/j.humimm.2022.12.003_b0035","first-page":"95","article-title":"Serum immunoglobulin levels in splenectomized and non- splenectomized patients with major Beta-thalassemia","volume":"21","author":"Kiani-Amin","year":"2011","journal-title":"Iran. J. Pediatr."},{"key":"10.1016\/j.humimm.2022.12.003_b0040","first-page":"50","article-title":"Qualitative evaluation of humoral immunity of \u03b2-thalassaemia patients by immunofixation test","volume":"1","author":"Mahmood","year":"2015","journal-title":"Int. J. Curr. Med. Pharm. Res."},{"key":"10.1016\/j.humimm.2022.12.003_b0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1097-0320(20000215)42:1<11::AID-CYTO3>3.0.CO;2-1","article-title":"Lymphocyte subsets and specific T-cell immune response in thalassemia","volume":"42","author":"Kovit Pattanapanyasat","year":"2002","journal-title":"Cytometry"},{"issue":"7","key":"10.1016\/j.humimm.2022.12.003_b0050","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3109\/08880018.2010.503334","article-title":"The role of Treg cells and FoxP3 expression in immunity of beta-thalassemia major AND beta-thalassemia trait patients","volume":"27","author":"Bozdogan","year":"2010","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.humimm.2022.12.003_b0055","unstructured":"A.K. Abbas., A.H. Lichtman., S. Pillai., Differentiation and Function of CD4+ Effector T cells, in: J. Merritt (Ed.) Cellular and Molecular Immunology, Elsevier, Philadelphia, 2018, pp. 225-242."},{"key":"10.1016\/j.humimm.2022.12.003_b0060","doi-asserted-by":"crossref","unstructured":"A.S. Khalifa, Z. Maged, R. Khalil, F. Sabri, O. Hassan, M. el-Alfy, T cell functions in infants and children with beta-thalassemia, Acta haematologica 79(3) (1988) 153-6.","DOI":"10.1159\/000205748"},{"issue":"1","key":"10.1016\/j.humimm.2022.12.003_b0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/088800102753356194","article-title":"Immunological status of thalassemia syndrome","volume":"19","author":"Ezer","year":"2002","journal-title":"Pediatr. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.humimm.2022.12.003_b0070","first-page":"893","article-title":"Altered T and B lymphocytes in multitransfused patients of thalassemia major","volume":"30","author":"Dua","year":"1993","journal-title":"Indian Pediatr."},{"issue":"3","key":"10.1016\/j.humimm.2022.12.003_b0075","first-page":"621","article-title":"Abnormalities in the immune system of children with beta-thalassaemia major","volume":"68","author":"Dwyer","year":"1987","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2022.12.003_b0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1097-0320(20000215)42:1<11::AID-CYTO3>3.0.CO;2-1","article-title":"Lymphocyte subsets and specific T-cell immune response in thalassemia","volume":"42","author":"Pattanapanyasat","year":"2000","journal-title":"Cytometry"},{"issue":"9","key":"10.1016\/j.humimm.2022.12.003_b0085","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/nprot.2007.296","article-title":"Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester","volume":"2","author":"Quah","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.humimm.2022.12.003_b0090","first-page":"1","article-title":"The use of carboxyfluorescein diacetate succinimidyl ester (CFSE) to monitor lymphocyte proliferation","volume":"44","author":"Quah","year":"2010","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.humimm.2022.12.003_b0095","unstructured":"A. Treister, M. Roederer, FlowJo Proliferation_tutorial. <www.Flowjo.com>, 1996 (accessed 1 January 2011.)."},{"issue":"5","key":"10.1016\/j.humimm.2022.12.003_b0100","first-page":"406","article-title":"Serum levels of cytokines and soluble antigens in polytransfused patients with beta-thalassemia major: relationship to immune status","volume":"79","author":"Lombardi","year":"1994","journal-title":"Haematologica"},{"key":"10.1016\/j.humimm.2022.12.003_b0105","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2022.12.003_b0110","doi-asserted-by":"crossref","first-page":"10297","DOI":"10.1038\/s41598-020-67346-2","article-title":"Immune responses in beta-thalassaemia: heme oxygenase 1 reduces cytokine production and bactericidal activity of human leucocytes","volume":"10","author":"Nithichanon","year":"2020","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.humimm.2022.12.003_b0115","first-page":"354","article-title":"Effects of iron overload on the immune system","volume":"30","author":"Walker","year":"2000","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"3","key":"10.1016\/j.humimm.2022.12.003_b0120","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1182\/blood.V64.3.748.748","article-title":"Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation","volume":"64","author":"Lederman","year":"1984","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humimm.2022.12.003_b0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40170-022-00284-x","article-title":"An iron chelation-based combinatorial anticancer therapy comprising deferoxamine and a lactate excretion inhibitor inhibits the proliferation of cancer cells","volume":"10","author":"Fujisawa","year":"2022","journal-title":"Can. Metabol."},{"key":"10.1016\/j.humimm.2022.12.003_b0130","unstructured":"Putu Niken Ayu Amrita, S. Ugroseno Yudho Bintoro, Made Putra Sedana, Muhammad Noordiansyah, Pradana Zaky Ramadhan, Merlyna Savitri, A. Ashariati, Serum ferritin level affects T lymphocyte CD4, CD8, and CD4CD8 ratio in transfussion-dependent beta-thalassemia, Drug Invention Today 13(6) (2020) 887-892."},{"issue":"2","key":"10.1016\/j.humimm.2022.12.003_b0135","first-page":"DC14-8","article-title":"Alteration of T cell subtypes in beta-thalassaemia major: impact of ferritin level","volume":"10","author":"Pourgheysari","year":"2016","journal-title":"J. Clin. Diagn. Res."},{"issue":"1","key":"10.1016\/j.humimm.2022.12.003_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-5-25","article-title":"Transfusion-transmitted infections","volume":"5","author":"Bihl","year":"2007","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.humimm.2022.12.003_b0145","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/infdis\/jiv369","article-title":"Cytomegalovirus-and Epstein-Barr Virus\u2013induced T-cell expansions in young children do not impair naive t-cell populations or vaccination responses: the generation R study","volume":"213","author":"Van Den Heuvel","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.humimm.2022.12.003_b0150","doi-asserted-by":"crossref","first-page":"e1005832","DOI":"10.1371\/journal.ppat.1005832","article-title":"Cytomegalovirus infection leads to development of high frequencies of cytotoxic virus-specific CD4+ T cells targeted to vascular endothelium","volume":"12","author":"Pachnio","year":"2016","journal-title":"PLoS Pathog."},{"issue":"18","key":"10.1016\/j.humimm.2022.12.003_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22189973","article-title":"Functional changes of T-cell subsets with age and CMV infection","volume":"22","author":"Hassouneh","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2022.12.003_b0160","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fcimb.2020.00202","article-title":"The CD4+ T cell response to human cytomegalovirus in healthy and immunocompromised people","volume":"10","author":"Lim","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.humimm.2022.12.003_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2020.05.001","article-title":"Understanding the mechanism of action of cytomegalovirus-induced regulatory T cells","volume":"547","author":"Tovar-Salazar","year":"2020","journal-title":"Virology"},{"key":"10.1016\/j.humimm.2022.12.003_b0170","doi-asserted-by":"crossref","unstructured":"J.Y. Humrich, H. Morbach, R. Undeutsch, P. Enghard, S. Rosenberger, O. Weigert, L. Kloke, J. Heimann, T. Gaber, S. Brandenburg, Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus, Proceedings of the National Academy of Sciences 107(1) (2010) 204-209.","DOI":"10.1073\/pnas.0903158107"},{"issue":"3","key":"10.1016\/j.humimm.2022.12.003_b0175","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/art.23291","article-title":"Interleukin-17\u2013producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers","volume":"58","author":"Nistala","year":"2008","journal-title":"Arthri. Rheumatism: Off. J. the Am. College Rheumatol."},{"issue":"6","key":"10.1016\/j.humimm.2022.12.003_b0180","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/rheumatology\/kep028","article-title":"Th17 and regulatory T cells: rebalancing pro-and anti-inflammatory forces in autoimmune arthritis","volume":"48","author":"Nistala","year":"2009","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.humimm.2022.12.003_b0185","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.24499","article-title":"Th17 and natural Treg cell population dynamics in systemic lupus erythematosus","volume":"60","author":"Yang","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.humimm.2022.12.003_b0190","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2020.07.022","article-title":"FoxP3+ T regulatory cells in cancer: prognostic biomarkers and therapeutic targets","volume":"490","author":"Saleh","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.humimm.2022.12.003_b0195","unstructured":"F. Segen's Medical Dictionary, Inc, METAVIR scoring system. <https:\/\/medical-dictionary.thefreedictionary.com\/METAVIR+scoring+system>, 2011 (accessed 04 November 2022.)."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885922002518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885922002518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:56:26Z","timestamp":1759319786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885922002518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0198885922002518"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2022.12.003","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unbalanced T-cell subsets in pediatric patients with beta-thalassemia","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2022.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}